{"entity":{"type":"insider","cik":"0001757940","url":"/insider/0001757940","json_url":"/insider/0001757940.json","name":"Perceptive Xontogeny Venture Fund, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":13,"first":"2021-02-08","last":"2025-02-21","span_basis":"filed_date"},"name_variants":[{"name":"Perceptive Xontogeny Venture Fund, LP","source":"filing","n_filings":13,"first_seen":"2021-02-08","last_seen":"2025-02-21"}],"transactions":[{"id":4197190,"accession":"0001062993-25-003153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-003153","line_url":"/filing/0001062993-25-003153#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; Perceptive Xontogeny Venture Fund, LP; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000000.0,"shares_display":"5,000,000","price_per_share":4.03,"price_display":"4.03","price_state":"stated","total_value":20150000.0,"total_display":"20,150,000.00","total_whole":"20,150,000","shares_owned_after":11833539.0,"shares_owned_after_display":"11,833,539","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":2751733,"accession":"0001062993-24-001979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-001979","line_url":"/filing/0001062993-24-001979#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Astria Therapeutics, Inc.","issuer_ticker":"ATXS","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"Perceptive Xontogeny Venture Fund, LP; PERCEPTIVE ADVISORS LLC; EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_display_name":"Perceptive Xontogeny Venture Fund, LP","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2481350.0,"shares_display":"2,481,350","price_per_share":12.09,"price_display":"12.09","price_state":"stated","total_value":29999521.5,"total_display":"29,999,521.50","total_whole":"29,999,522","shares_owned_after":4873721.0,"shares_owned_after_display":"4,873,721","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider"},{"id":2835326,"accession":"0001062993-24-000843","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-000843","line_url":"/filing/0001062993-24-000843#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Solid Biosciences Inc.","issuer_ticker":"SLDB","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; Perceptive Xontogeny Venture Fund, LP; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3410713.0,"shares_display":"3,410,713","price_per_share":5.53,"price_display":"5.53","price_state":"stated","total_value":18861242.89,"total_display":"18,861,242.89","total_whole":"18,861,243","shares_owned_after":6833539.0,"shares_owned_after_display":"6,833,539","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-12","scope":"insider"},{"id":8402719,"accession":"0001062993-23-023077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-023077","line_url":"/filing/0001062993-23-023077#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Astria Therapeutics, Inc.","issuer_ticker":"ATXS","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; EDELMAN JOSEPH; Perceptive Xontogeny Venture Fund, LP","owner_display_name":"PERCEPTIVE ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":740000.0,"shares_display":"740,000","price_per_share":6.2,"price_display":"6.20","price_state":"stated","total_value":4588000.0,"total_display":"4,588,000.00","total_whole":"4,588,000","shares_owned_after":2392371.0,"shares_owned_after_display":"2,392,371","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-22","scope":"insider"},{"id":8219034,"accession":"0001062993-23-019533","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-019533","line_url":"/filing/0001062993-23-019533","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Astria Therapeutics, Inc.","issuer_ticker":"ATXS","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"Perceptive Xontogeny Venture Fund, LP; EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD","owner_display_name":"Perceptive Xontogeny Venture Fund, LP","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1074608.0,"shares_display":"1,074,608","price_per_share":6.514,"price_display":"6.51","price_state":"stated","total_value":6999996.512,"total_display":"6,999,996.51","total_whole":"6,999,997","shares_owned_after":1652371.0,"shares_owned_after_display":"1,652,371","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-18","scope":"insider","n_lines":2},{"id":6808546,"accession":"0001062993-22-024291","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-024291","line_url":"/filing/0001062993-22-024291#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Astria Therapeutics, Inc.","issuer_ticker":"ATXS","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; PERCEPTIVE ADVISORS LLC; Perceptive Xontogeny Venture Fund, LP","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":908265.0,"shares_display":"908,265","price_per_share":11.01,"price_display":"11.01","price_state":"stated","total_value":9999997.65,"total_display":"9,999,997.65","total_whole":"9,999,998","shares_owned_after":1038309.0,"shares_owned_after_display":"1,038,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-21","scope":"insider"},{"id":6170178,"accession":"0001062993-22-018544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-018544","line_url":"/filing/0001062993-22-018544#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; LEV LB Holdings, LP; Perceptive Xontogeny Venture Fund, LP; Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":998240.0,"shares_display":"998,240","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":2395776.0,"total_display":"2,395,776.00","total_whole":"2,395,776","shares_owned_after":3728491.0,"shares_owned_after_display":"3,728,491","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-18","filed_date":"2022-08-22","scope":"insider"},{"id":6695504,"accession":"0001062993-22-013616","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-013616","line_url":"/filing/0001062993-22-013616#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; LEV LB Holdings, LP; C2 Life Sciences LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; LEV LB Holdings GP, LLC; Perceptive Xontogeny Venture Fund, LP; Perceptive Venture Advisors, LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69000.0,"shares_display":"69,000","price_per_share":3.13,"price_display":"3.13","price_state":"stated","total_value":215970.0,"total_display":"215,970.00","total_whole":"215,970","shares_owned_after":2730251.0,"shares_owned_after_display":"2,730,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-27","scope":"insider"},{"id":6717151,"accession":"0001062993-22-013535","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-22-013535","line_url":"/filing/0001062993-22-013535#line-3","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; EDELMAN JOSEPH; LEV LB Holdings, LP; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"Perceptive Venture Advisors, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120000.0,"shares_display":"120,000","price_per_share":2.63,"price_display":"2.63","price_state":"stated","total_value":315600.0,"total_display":"315,600.00","total_whole":"315,600","shares_owned_after":2661251.0,"shares_owned_after_display":"2,661,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-25","scope":"insider"},{"id":6717149,"accession":"0001062993-22-013535","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-22-013535","line_url":"/filing/0001062993-22-013535#line-2","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; EDELMAN JOSEPH; LEV LB Holdings, LP; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"Perceptive Venture Advisors, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42551.0,"shares_display":"42,551","price_per_share":2.47,"price_display":"2.47","price_state":"stated","total_value":105100.97,"total_display":"105,100.97","total_whole":"105,101","shares_owned_after":2541251.0,"shares_owned_after_display":"2,541,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider"},{"id":6717145,"accession":"0001062993-22-013535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-22-013535","line_url":"/filing/0001062993-22-013535#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; EDELMAN JOSEPH; LEV LB Holdings, LP; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"Perceptive Venture Advisors, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"American Depositary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8700.0,"shares_display":"8,700","price_per_share":2.49,"price_display":"2.49","price_state":"stated","total_value":21663.0,"total_display":"21,663.00","total_whole":"21,663","shares_owned_after":2498700.0,"shares_owned_after_display":"2,498,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider"},{"id":4718855,"accession":"0001062993-21-010295","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-010295","line_url":"/filing/0001062993-21-010295","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; LEV LB Holdings GP, LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; LEV LB Holdings, LP; Perceptive Xontogeny Venture Fund, LP; Perceptive Venture Advisors, LLC; PERCEPTIVE ADVISORS LLC; C2 Life Sciences LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2270000.0,"shares_display":"2,270,000","price_per_share":15.97806167400881,"price_display":"15.98","price_state":"stated","total_value":36270200.0,"total_display":"36,270,200.00","total_whole":"36,270,200","shares_owned_after":27838895.0,"shares_owned_after_display":"27,838,895","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-03","filed_date":"2021-11-05","scope":"insider","n_lines":2},{"id":4163906,"accession":"0000899243-21-042807","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-042807","line_url":"/filing/0000899243-21-042807#line-2","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; LEV LB Holdings, LP; Perceptive Xontogeny Venture Fund, LP; Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":1350000.0,"total_display":"1,350,000.00","total_whole":"1,350,000","shares_owned_after":7253885.0,"shares_owned_after_display":"7,253,885","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider"},{"id":4163901,"accession":"0000899243-21-042807","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-042807","line_url":"/filing/0000899243-21-042807#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"LianBio","issuer_ticker":"LIAN","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; LEV LB Holdings, LP; Perceptive Xontogeny Venture Fund, LP; Perceptive Venture Advisors, LLC; LEV LB Holdings GP, LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; C2 Life Sciences LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120000.0,"shares_display":"120,000","price_per_share":15.5,"price_display":"15.50","price_state":"stated","total_value":1860000.0,"total_display":"1,860,000.00","total_whole":"1,860,000","shares_owned_after":7153885.0,"shares_owned_after_display":"7,153,885","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider"},{"id":4126229,"accession":"0001062993-21-001115","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-21-001115","line_url":"/filing/0001062993-21-001115","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Landos Biopharma, Inc.","issuer_ticker":"LABP","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; Xontogeny, LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":99681.0,"shares_display":"99,681","price_per_share":14.080502803944583,"price_display":"14.08","price_state":"stated","total_value":1403558.6,"total_display":"1,403,558.60","total_whole":"1,403,559","shares_owned_after":7264800.0,"shares_owned_after_display":"7,264,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider","n_lines":2},{"id":4209218,"accession":"0001062993-21-001012","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-21-001012","line_url":"/filing/0001062993-21-001012#line-6","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Landos Biopharma, Inc.","issuer_ticker":"LABP","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"Perceptive Xontogeny Venture Fund, LP; EDELMAN JOSEPH; Xontogeny, LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; PERCEPTIVE ADVISORS LLC","owner_display_name":"Perceptive Xontogeny Venture Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":20000000.0,"total_display":"20,000,000.00","total_whole":"20,000,000","shares_owned_after":7049564.0,"shares_owned_after_display":"7,049,564","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-08","scope":"insider"},{"id":4126224,"accession":"0001062993-21-001115","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-21-001115","line_url":"/filing/0001062993-21-001115","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Landos Biopharma, Inc.","issuer_ticker":"LABP","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; Xontogeny, LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":123053.0,"shares_display":"123,053","price_per_share":12.21474413464117,"price_display":"12.21","price_state":"stated","total_value":1503060.91,"total_display":"1,503,060.91","total_whole":"1,503,061","shares_owned_after":7198299.0,"shares_owned_after_display":"7,198,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider","n_lines":3},{"id":4126203,"accession":"0001062993-21-001115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-001115","line_url":"/filing/0001062993-21-001115#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Landos Biopharma, Inc.","issuer_ticker":"LABP","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; Xontogeny, LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27453.0,"shares_display":"27,453","price_per_share":11.14,"price_display":"11.14","price_state":"stated","total_value":305826.42,"total_display":"305,826.42","total_whole":"305,826","shares_owned_after":7077017.0,"shares_owned_after_display":"7,077,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001707502","name":"Solid Biosciences Inc.","url":"/issuer/0001707502","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2024-01-12","last_seen":"2025-02-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001454789","name":"Astria Therapeutics, Inc.","url":"/issuer/0001454789","role":"Director","n_filings":4,"first_seen":"2022-12-21","last_seen":"2024-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001831283","name":"LianBio","url":"/issuer/0001831283","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2021-11-03","last_seen":"2022-08-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001785345","name":"Landos Biopharma, Inc.","url":"/issuer/0001785345","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2021-02-08","last_seen":"2021-02-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001757940","retrieved_at":"2026-08-26T07:31:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}